SOAT1 and Immunodeficiency: As discussed, patients with genetic mutations affecting Jak‐STAT signalling display various immune deficiencies and biological drugs and small molecule inhibitors commonly prescribed in various disease settings often target STAT‐activating cytokines (e.g. or Jak activation) [1, 169, 171].